FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance

For many years, disappointing results have been generated by many investigations, which have utilized a variety of immunologic strategies to enhance the ability of a patient’s immune system to recognize and eliminate malignant cells. However, in recent years, immunotherapy has been used successfully...

詳細記述

保存先:
書誌詳細
出版年:Front Immunol
主要な著者: Caratelli, Sara, Sconocchia, Tommaso, Arriga, Roberto, Coppola, Andrea, Lanzilli, Giulia, Lauro, Davide, Venditti, Adriano, Del Principe, Maria Ilaria, Buccisano, Francesco, Maurillo, Luca, Ferrone, Soldano, Sconocchia, Giuseppe
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2017
主題:
Immunology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5406408/
https://ncbi.nlm.nih.gov/pubmed/28496440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.00457
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料